Jin Liang, Feng Tao, Chai Jing, Ghazalli Nadiah, Gao Dan, Zerda Ricardo, Li Zhuo, Hsu Jasper, Mahdavi Alborz, Tirrell David A, Riggs Arthur D, Ku Hsun Teresa
Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
Electron Microscopy Core, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
Rev Diabet Stud. 2014 Spring;11(1):35-50. doi: 10.1900/RDS.2014.11.35. Epub 2014 May 10.
In our previous studies, colony-forming progenitor cells isolated from murine embryonic stem cell-derived cultures were differentiated into morphologically distinct insulin-expressing colonies. These colonies were small and not light-reflective when observed by phase-contrast microscopy (therefore termed "Dark" colonies). A single progenitor cell capable of giving rise to a Dark colony was termed a Dark colony-forming unit (CFU-Dark). The goal of the current study was to test whether endogenous pancreas, and its developmentally related liver, harbored CFU-Dark. Here we show that dissociated single cells from liver and pancreas of one-week-old mice give rise to Dark colonies in methylcellulose-based semisolid culture media containing either Matrigel or laminin hydrogel (an artificial extracellular matrix protein). CFU-Dark comprise approximately 0.1% and 0.03% of the postnatal hepatic and pancreatic cells, respectively. Adult liver also contains CFU-Dark, but at a much lower frequency (~0.003%). Microfluidic qRT-PCR, immunostaining, and electron microscopy analyses of individually handpicked colonies reveal the expression of insulin in many, but not all, Dark colonies. Most pancreatic insulin-positive Dark colonies also express glucagon, whereas liver colonies do not. Liver CFU-Dark require Matrigel, but not laminin hydrogel, to become insulin-positive. In contrast, laminin hydrogel is sufficient to support the development of pancreatic Dark colonies that express insulin. Postnatal liver CFU-Dark display a cell surface marker CD133⁺CD49f(low)CD107b(low) phenotype, while pancreatic CFU-Dark are CD133⁻. Together, these results demonstrate that specific progenitor cells in the postnatal liver and pancreas are capable of developing into insulin-expressing colonies, but they differ in frequency, marker expression, and matrix protein requirements for growth.
在我们之前的研究中,从小鼠胚胎干细胞衍生培养物中分离出的集落形成祖细胞分化为形态上不同的胰岛素表达集落。通过相差显微镜观察时,这些集落较小且不反光(因此称为“暗”集落)。能够产生暗集落的单个祖细胞称为暗集落形成单位(CFU-Dark)。本研究的目的是测试内源性胰腺及其发育相关的肝脏中是否存在CFU-Dark。在这里,我们表明,来自一周龄小鼠肝脏和胰腺的解离单细胞在含有基质胶或层粘连蛋白水凝胶(一种人工细胞外基质蛋白)的甲基纤维素基半固体培养基中产生暗集落。CFU-Dark分别约占出生后肝脏和胰腺细胞的0.1%和0.03%。成年肝脏中也含有CFU-Dark,但频率要低得多(约0.003%)。对逐个挑选的集落进行微流控qRT-PCR、免疫染色和电子显微镜分析发现,许多(但不是所有)暗集落中都有胰岛素表达。大多数胰腺胰岛素阳性暗集落也表达胰高血糖素,而肝脏集落则不表达。肝脏CFU-Dark需要基质胶才能变成胰岛素阳性,而层粘连蛋白水凝胶则不需要。相比之下,层粘连蛋白水凝胶足以支持表达胰岛素的胰腺暗集落的发育。出生后肝脏CFU-Dark表现出细胞表面标志物CD133⁺CD49f(低)CD107b(低)表型,而胰腺CFU-Dark为CD133⁻。总之,这些结果表明,出生后肝脏和胰腺中的特定祖细胞能够发育成胰岛素表达集落,但它们在频率、标志物表达和生长所需的基质蛋白方面存在差异。